2021
Are hematopoietic cell transplant recipients with Gram‐negative bacteremia spending more time outpatient while on intravenous antibiotics? Addressing trends over 10 years at a single center
Lind M, Roncaioli S, Liu C, Bryan A, Sweet A, Tverdek F, Sorror M, Phipps A, Pergam S. Are hematopoietic cell transplant recipients with Gram‐negative bacteremia spending more time outpatient while on intravenous antibiotics? Addressing trends over 10 years at a single center. Immunity Inflammation And Disease 2021, 9: 1786-1794. PMID: 34289529, PMCID: PMC8589361, DOI: 10.1002/iid3.486.Peer-Reviewed Original ResearchConceptsGram-negative rod bacteremiaAllogeneic HCT recipientsOutpatient antibiotic treatmentHematopoietic cell transplantationHCT recipientsProportion of treatment timePosttransplant complicationsAntibiotic treatmentAllogeneic hematopoietic cell transplantationHematopoietic cell transplant recipientsOutpatient settingAntibiotic treatment timeBroad-spectrum antibioticsIntravenous antibioticsCell transplantationTransplant recipientsDays posttransplantationTreatment optionsTreatment timePatientsTreatment managementComplicationsInfection characteristicsRecipientsAmbulatory care setting
2020
Trends in the Proportion of Time Spent Outpatient While Receiving Antibiotics for Treatment of Gram-Negative Rod Bacteremia Among Allogeneic Hematopoietic Cell Transplant Recipients
Lind M, Roncaioli S, Phipps A, Liu C, Bryant A, Sweet A, Pergam S. Trends in the Proportion of Time Spent Outpatient While Receiving Antibiotics for Treatment of Gram-Negative Rod Bacteremia Among Allogeneic Hematopoietic Cell Transplant Recipients. Transplantation And Cellular Therapy 2020, 26: s320-s321. DOI: 10.1016/j.bbmt.2019.12.343.Peer-Reviewed Original ResearchGram-negative rod bacteremiaAllogeneic HCT recipientsProportion of treatment timeHematopoietic cell transplantationMultidrug-resistant organismsHCT recipientsAllogeneic hematopoietic cell transplant recipientsInpatient intravenous antibiotic therapyAllogeneic hematopoietic cell transplantationHematopoietic cell transplant recipientsOutpatient settingIntravenous antibiotic therapySeverity of illnessMDR statusAntibiotic durationBlood culturesAntibiotic therapyCell transplantationTransplant recipientsReceiving antibioticsAdult patientsAntibiotic treatmentTreatment timeAntibiotic deliveryOutpatient management